Suppr超能文献

自体血小板浓缩物的三十年:从富血小板血浆到富血小板纤维蛋白。

Thirty Years of Autologous Platelet Concentrates: From Platelet-Rich Plasma to Platelet-Rich Fibrin.

作者信息

Miron Richard J, Estrin Nathan E, Ahmad Paras, Farshidfar Nima, Fujioka-Kobayashi Masako, Zhang Yufeng, Romandini Mario, Gruber Reinhard

机构信息

Department of Periodontology, University of Bern, Bern, Switzerland.

Lake Erie College of Osteopathic Medicine School of Dental Medicine, Bradenton, Florida, USA.

出版信息

J Periodontal Res. 2025 Aug 4. doi: 10.1111/jre.70013.

Abstract

Nearly three decades have now passed since autologous platelet concentrates (APCs) were introduced into clinical practice. Harnessing the body's innate intrinsic capacity for healing, the concepts of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) emerged to concentrate growth factors and cells at supra-physiological levels. Nearly three decades ago, Professor Robert Marx demonstrated that PRP-obtained via centrifugation of whole blood with anti-coagulants-could accelerate healing across a wide range of indications in both dentistry and medicine. Subsequent research showed that eliminating anti-coagulants, leading to the development of PRF, resulted in an even more natural and faster healing process. In dentistry, APCs have been consistently shown to accelerate healing of both soft and hard tissues, either as standalone treatments or in combination with other biomaterials. PRF, in particular, has demonstrated benefits within several dental applications, spanning from root coverage, periodontal regeneration of intra-bony and furcation defects, ridge preservation, third molar extraction healing, sinus grafting, guided bone regeneration (GBR), and peri-implant soft tissue healing. Beyond dentistry, PRF has also proven effective in various medical indications-improving outcomes in the treatment of diabetic ulcers, managing joint pain and cartilage degradation in sports medicine, and enhancing outcomes in esthetic medicine. This review highlights the evolution of APCs, with a focus on their clinical applications and recent technological advancements. These include horizontal centrifugation techniques for PRF and more refined protocols for producing concentrated PRF (C-PRF). Lastly, the article introduces extended-PRF (e-PRF) membranes, created through heat-induced albumin denaturation, which prolong membrane degradation from the typical 2-3 weeks to up to 4 months. These innovative e-PRF membranes, composed of albumin gel and liquid PRF (Alb-PRF), are now being used as alternatives to collagen membranes in routine dental procedures.

摘要

自自体血小板浓缩物(APCs)被引入临床实践至今已过去近三十年。利用人体自身固有的愈合能力,富含血小板血浆(PRP)和富含血小板纤维蛋白(PRF)的概念应运而生,旨在将生长因子和细胞浓缩至超生理水平。近三十年前,罗伯特·马克思教授证明,通过用抗凝剂对全血进行离心获得的PRP能够加速牙科和医学领域多种适应症的愈合。随后的研究表明,去除抗凝剂从而开发出PRF,可带来更自然、更快的愈合过程。在牙科领域,APCs一直被证明能够加速软组织和硬组织的愈合,无论是作为单独治疗还是与其他生物材料联合使用。特别是PRF,已在多种牙科应用中展现出优势,包括牙根覆盖、骨内和根分叉缺损的牙周再生、牙槽嵴保存、第三磨牙拔除后的愈合、鼻窦植骨、引导骨再生(GBR)以及种植体周围软组织愈合。在牙科领域之外,PRF在各种医学适应症中也被证明是有效的,可改善糖尿病溃疡的治疗效果、处理运动医学中的关节疼痛和软骨退化问题,以及提高美容医学的治疗效果。本综述重点介绍了APCs的发展历程,着重阐述其临床应用和近期的技术进展。这些进展包括用于PRF的水平离心技术以及生产浓缩PRF(C-PRF)的更精细方案。最后,本文介绍了通过热诱导白蛋白变性制成的扩展PRF(e-PRF)膜,它将膜的降解时间从通常的2至3周延长至长达4个月。这些由白蛋白凝胶和液体PRF(Alb-PRF)组成的创新性e-PRF膜,如今在常规牙科手术中被用作胶原膜的替代品。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验